Featured Articles

Aplastic anemia

This somewhat misleading term is applied to pancytopenia characterized by (1) anemia (2) neutropenia and (3) thrombocyt...

Biovail, Schering-Plough Terminate ...

TORONTO -- Biovail Corporation (NYSE:BVF) (TSX:BVF) announced today that it has terminated its sub-licensing and manuf...

9 Natural Remedies to Cure your Ins...

Are you unsatisfied with your quality of sleep? Do you feel tired and un-refreshed on waking in the morning? Do you stay...

Merck Announces JANUMET(TM), the Tr...

WHITEHOUSE STATION, N.J. -- Merck & Co., Inc. today announced the trademark JANUMET[TM] for MK-0431A, the Company...

Cellular schwannoma of the paranasa...

Abstract Cellular schwannomas are a benign variant of classic schwannomas. Their histologic appearance closely mimic...

FIND A DRUG

Pharmacy Locator

ZIP Distance

Use this tool to find
pharmacies in your area

Drug Information Related to Pegvisomant

Back

01. Shearwater Polymers Signs Agreement for New Acromegaly Drug. - Free .....

Business Editors/Health and Medical Writers HUNTSVILLE, Ala.--(BW HealthWire)--April 4, 2000 Shearwater shearwater, common name for members of the family Procellariidae, gull-like sea birds related to the petrel and the albatross and including the fulmar....

02. Ipsen Strikes Alliance with the Erasmus University Medical Centre ......

PARIS -- Ipsen (ISIN:FR0010259150) (Paris:IPN IPN - I'm Posting NakedIPN - Ideal Proportional NavigationIPN - Impulse NoiseIPN - Infectious Pancreatic NecrosisIPN - Info Pool NetworkIPN - Initial Physical Notification (UK)IPN - Instant Payment Notification (PayPal)IP...

03. Ipsen and Tercica to Enter into Worldwide Strategic Collaboration in ....

PARIS & BRISBANE, Calif. -- Tercica (Nasdaq:TRCA TRCA - Terminal Radar Control Area (FAA)TRCA - Toronto and Region Conservation AuthorityTRCA - Trademark Remedy Clarification Act):--Cross licensing agreements for Somatuline(R) Autogel(R) and Increlex(TM)--Ipsen t...

04. FDA approvals. for acromegaly treatment; enfuvirtide for HIV treatment...

* Pegvisomant. The U.S. Food and Drug Administration (FDA) has approved pegvisomant (Somavert) for the treatment of acromegaly in patients who have had an inadequate response to existing therapies. ...

05. Somavert | OB/GYN News | Find Articles at BNET

(pegvisomant for injection, Pharmacia) ...

06. Valera Pharmaceuticals Completes Enrollment for a Phase II Study of a ...

CRANBURY, N.J. -- 2004 Seen as Milestone Year in Advancing Valera's Pipeline Toward Commercialization ...